Results of the ALLHAT trial: is the debate about initial antihypertensive drug therapy over?
- PMID: 12556646
- PMCID: PMC8099297
- DOI: 10.1111/j.1524-6175.2003.02259.x
Results of the ALLHAT trial: is the debate about initial antihypertensive drug therapy over?
Abstract
Results of the ALLHAT study have focused attention on the preferred approaches to the management of hypertension. Some of the conclusions of this trial have already been questioned. In this issue of The JCH, Marvin Moser, MD, and Michael A. Weber, MD, two of the senior editors, present their critiques of the ALLHAT results.
References
-
- Antihypertensive Therapy and Lipid Lowering Heart Attack Trial (ALLHAT) Collaborative Research Group . Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone: the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial. JAMA. 2000;283:1967–1975. - PubMed
-
- Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens. 2002;4:393–404. - PubMed
-
- Ames RP. The influence of non β‐blocking drugs on the lipid profile: are diuretics outclassed as initial therapy for hypertension? Am Heart J. 1987;114:998–1006. - PubMed
-
- Zussman RM. Alternatives to traditional antihypertensive therapy [editorial]. Hypertens. 1986;8:837–842. - PubMed
-
- Houston MC. New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension. Am Heart J. 1989;117:911–949. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical